Literature DB >> 286331

Amidolytic properties of single-chain activated Hageman factor.

O D Ratnoff, H Saito.   

Abstract

Activation of Hageman factor (Factor XII) upon exposure to negatively charged agents has been attributed to proteolytic cleavage of this molecule. To examine this question, purified Hageman factor was exposed to Sephadex gels to which ellagic acid had been adsorbed. Such Hageman factor, separated from the gels and studied in the fluid phase, was amidolytic. Nonetheless, no cleavage of Hageman factor treated in this way could be demonstrated by sodium dodecyl sulfate/polyacrylamide gel electrophoresis. Thus, activation of Hageman factor by negatively charged agents was not necessarily accompanied by molecular scission.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 286331      PMCID: PMC383272          DOI: 10.1073/pnas.76.3.1461

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Purification of high molecular weight kininogen and the role of this agent in blood coagulation.

Authors:  H Saito
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

2.  Characterization of bovine factor XIIa (activated Hageman factor).

Authors:  K Fujikawa; K Kurachi; E W Davie
Journal:  Biochemistry       Date:  1977-09-20       Impact factor: 3.162

3.  Detection by fluorescence of structural changes accompanying the activation of Hageman factor (factor XII).

Authors:  B D Fair; H Saito; O D Ratnoff; W B Rippon
Journal:  Proc Soc Exp Biol Med       Date:  1977-06

4.  Structural changes accompanying enzymatic activation of human Hageman factor.

Authors:  S D Revak; C G Cochrane; A R Johnston; T E Hugli
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

5.  Inhibition of the adsorption of Hagemen factor (Factor XII) to glass by normal human plasma.

Authors:  H Saito; O D Ratnoff; V H Donaldson; G Haney; J Pensky
Journal:  J Lab Clin Med       Date:  1974-07

6.  Inhibition of normal clotting and Fletcher factor activity by rabbit anti-kallikrein antiserum.

Authors:  H Saito; O D Ratnoff
Journal:  Nature       Date:  1974-04-12       Impact factor: 49.962

7.  Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.

Authors:  O D Ratnoff; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

8.  The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.

Authors:  S D Revak; C G Cochrane; J H Griffin
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

9.  Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein.

Authors:  C G Cochrane; S D Revak; K D Wuepper
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

10.  Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.

Authors:  S D Revak; C G Cochrane; B N Bouma; J H Griffin
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Single-chain factor XII: a new form of activated factor XII.

Authors:  Ivan Ivanov; Anton Matafonov; David Gailani
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

2.  Isolation and properties of an abnormal Hageman factor (Factor XII) molecule in a cross-reacting material-positive hageman trait plasma.

Authors:  H Saito; S J Scialla
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

3.  High molecular weight kininogen binds to unstimulated platelets.

Authors:  E J Gustafson; D Schutsky; L C Knight; A H Schmaier
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

4.  Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.

Authors:  Ivan Ivanov; Anton Matafonov; Mao-Fu Sun; Qiufang Cheng; S Kent Dickeson; Ingrid M Verhamme; Jonas Emsley; David Gailani
Journal:  Blood       Date:  2017-01-09       Impact factor: 22.113

5.  Protease activity in single-chain prekallikrein.

Authors:  Ivan Ivanov; Ingrid M Verhamme; Mao-Fu Sun; Bassem Mohammed; Qiufang Cheng; Anton Matafonov; S Kent Dickeson; Kusumam Joseph; Allen P Kaplan; David Gailani
Journal:  Blood       Date:  2020-02-20       Impact factor: 25.476

Review 6.  Proteolytic activity of contact factor zymogens.

Authors:  Aleksandr Shamanaev; Jonas Emsley; David Gailani
Journal:  J Thromb Haemost       Date:  2020-12-07       Impact factor: 5.824

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.